期刊
JOURNAL OF FUNCTIONAL FOODS
卷 97, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jff.2022.105260
关键词
Fibromyalgia; Neuropathic pain; Neurotransmitters; Nutraceuticals; Spinal cord injury; Spared nerve injury
Distinguishing between neuropathy and fibromyalgia for adequate care is difficult. These pain syndromes have become a significant challenge for healthcare experts due to their complex etiology and limited drug availability. Patients seeking relief from chronic pain conditions have turned to nutraceuticals as an alternative, but research on their safety and efficacy is lacking.
Though both neuropathy and fibromyalgia are serious complications that cause widespread pain, distinguishing between the two in order to provide adequate care is difficult. Metabolic disorders, chemotherapy, and neurotoxic exposure are frequently reported with neuropathic pain, whereas inflammatory and musculoskeletal diseases are associated with fibromyalgia. In recent years, these pain syndromes have become a significant challenge for healthcare experts due to their complex etiology, limited drug availability, and effectiveness. Notably, pharmaceutical drugs (antidepressants, anticonvulsants) available today have adverse effects, including physical dependence and tolerance. Therefore, a plethora of nutraceuticals has drawn considerable attention from patients seeking relief from chronic pain conditions. Nonetheless, only a few preclinical and clinical studies have been conducted to establish the safety and efficacy of these supplements. The current review concentrates on the role of a variety of nutraceuticals in the treatment of neuropathic pain and fibromyalgia, as well as their potential mechanisms and clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据